Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma

Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma

Glioblastomas, accounting for approximately 50% of gliomas, comprise the most aggressive, highly heterogeneous, and malignant brain tumors. The objective of this study was to develop and evaluate a new targeted therapy, i.e., highly potent natural compound verrucarin A (Ver-A), delivered with monocl...

Full description

Bibliographic Details
Main Authors: Kai Chen, Yingnan Si, Jia-Shiung Guan, Zhuoxin Zhou, Seulhee Kim, Taehyun Kim, Liang Shan, Christopher D. Willey, Lufang Zhou, Xiaoguang Liu
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Biomedicines
Subjects:
glioblastoma
targeted delivery
monoclonal antibody-directed extracellular vesicle
natural compound verrucarin A
Online Access:https://www.mdpi.com/2227-9059/10/1/130

Internet

https://www.mdpi.com/2227-9059/10/1/130

Similar Items